Company: SCLXW
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0000950170-25-047800
Chunk: 283

Company: Scilex Holding Co
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1B
Chunk 283
---
 2,685

    —

    Derivative liabilities

    18,303

    1,518

    Operating lease liabilities, net of current portion

    1,523

    2,237

    Other long-term liabilities

    155

    179

    Total liabilities

    285,594

    274,247

    Commitments and contingencies (See Note 11)

    Stockholders’ deficit:

    Preferred stock, $0.0001 par value, 45,000,000 shares authorized

    Series A, 29,057,097 shares issued and outstanding as of each of December 31, 2024 and December 31, 2023

    —

    —

    Series 1, 5,000,000 shares declared as a stock dividend, not yet distributed as of December 31, 2024; no shares authorized, issued and outstanding as of December 31, 2023

    1

    —

    Common stock, $0.0001 par value, 740,000,000 shares authorized; 243,312,885 shares issued and 183,244,300 shares outstanding as of December 31, 2024; 160,084,250 shares issued and 100,015,665 shares outstanding as of December 31, 2023

    24

    16

    Additional paid-in capital

    454,591

    407,813

    Accumulated other comprehensive income

    6,317

    —

    Accumulated deficit

    (563,052
    )

    (490,245
    )

    Treasury stock, at cost; 60,068,585 shares as of each of December 31, 2024 and December 31, 2023

    (90,522
    )

    (90,522
    )

    Total stockholders’ deficit

    (192,641
    )

    (172,938
    )

    Total liabilities and stockholders’ deficit
     
    $
    92,953

    $
    101,309

See accompanying notes to audited consolidated financial statements

 F-3

SCILEX HOLDING COMPANY 

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(In thousands, except for net loss per share amounts)

    Year Ended December 31,